Production (Stage)
Atai Life Sciences N.V.
ATAI
$2.32
$0.1054.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.43M | -38.96M | -26.29M | -57.31M | -26.71M |
| Total Depreciation and Amortization | 216.00K | 225.00K | 83.00K | 82.00K | 83.00K |
| Total Amortization of Deferred Charges | 149.00K | 188.00K | 131.00K | 98.00K | 98.00K |
| Total Other Non-Cash Items | 9.95M | 18.29M | 9.76M | 38.02M | 8.97M |
| Change in Net Operating Assets | -1.73M | -4.04M | -3.03M | 2.88M | -5.01M |
| Cash from Operations | -17.84M | -24.30M | -19.34M | -16.23M | -22.57M |
| Capital Expenditure | -1.02M | -6.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 359.00K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.00M | 6.21M | 24.84M | 16.30M | 11.47M |
| Cash from Investing | -11.01M | 6.56M | 24.84M | 16.30M | 11.47M |
| Total Debt Issued | -- | 0.00 | 5.00M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 60.17M | 154.00K | 55.00K | 326.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -564.00K | 0.00 | -161.00K | -- | -- |
| Cash from Financing | 59.61M | 154.00K | 4.89M | 326.00K | -- |
| Foreign Exchange rate Adjustments | 32.00K | 123.00K | 237.00K | 66.00K | -64.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -1.00K |
| Net Change in Cash | 30.78M | -17.46M | 10.63M | 465.00K | -11.17M |